Long Synthetic Forward: Replicate Stock Ownership Without Buying Shares
The synthetic forward gives you dollar-for-dollar stock exposure using options instead of cash. Same payoff, 80% less capital—but absolutely brutal to analyze in Excel. Here's how AI turns capital efficiency calculations into plain English conversation.
Andrew Grosser
February 16, 2026 • 13 min read
February 2024: NVDA is trading at $875. You're bullish for the next 90 days and want exposure to 200 shares. Traditional approach? Write a check for $175,000. Or tap your margin account for $87,500 at 8% annual interest—that's $1,750 in borrowing costs over three months. There's a third option that traders discovered decades ago: create a synthetic long stock position using options.
The mechanics are beautifully simple. Buy the $870 call for $32.50. Sell the $870 put for $28.00. Your net cost is $4.50 per share, or $900 per contract. Two contracts cost $1,800 in capital. But here's the magic: you now have exposure to 200 shares of NVDA for 98.9% less capital than buying the stock outright. Your profit and loss move dollar-for-dollar with the stock—exactly like ownership—but your capital commitment is a rounding error.
Or you upload your options data to Sourcetable and ask questions in plain English. Try it free.
What Makes Synthetic Forwards So Difficult to Analyze
A synthetic forward isn't one trade—it's a perfectly balanced two-leg options position that replicates stock ownership. You're simultaneously buying a call (bullish) and selling a put (bullish) at the same strike price with the same expiration. The result is a payoff diagram that mirrors owning 100 shares, with one crucial difference: your capital requirement is a fraction of the stock price.
Let's return to NVDA at $875. Here's what a real synthetic forward looks like:
- Buy the $870 call for $32.50 (you pay premium for upside exposure)
- Sell the $870 put for $28.00 (you collect premium, accepting downside obligation)
- Net debit: $4.50 per share ($3,250 − $2,800 = $450 per contract)
- Breakeven: $874.50 (strike + net debit)
- P&L behavior: Above $874.50, you profit dollar-for-dollar. Below $874.50, you lose dollar-for-dollar—exactly like owning stock at $874.50.
Here's where Excel becomes a nightmare:
- You need to calculate net debit or credit dynamically as option prices fluctuate throughout the day.
- You need to determine exact breakeven points that account for the net premium paid or collected.
- You need to model payoff at expiration across a range of stock prices to verify dollar-for-dollar replication.
- You need to calculate margin requirements (which vary by broker) and compare against stock purchase costs.
- You need to factor in dividends—which you miss—and interest costs—which you avoid.
- You need to track delta, gamma, theta, and vega to understand how the position behaves before expiration.
- You need to compare return on capital for synthetic versus stock across multiple scenarios.
That's seven separate analytical workflows, each requiring live data updates and recalculation. And if you're evaluating synthetic forwards at three different strikes across two expirations? You're managing 42 separate calculations. Copy one formula wrong and your entire analysis is worthless.
How Sourcetable Turns Synthetic Forward Analysis Into a Conversation
Sourcetable doesn't eliminate the complexity—it eliminates the manual labor of managing the complexity. Upload your options chain data (CSV from your broker, Excel file, or API connection), and the AI handles everything else. You interact with your synthetic forward analysis the same way you'd interact with a junior analyst who actually knows options math.
Instant Net Debit Calculation
In Excel, you'd create columns for leg type (long call, short put), strike prices, premiums, position quantity, then write a SUM formula accounting for sign conventions. Change one premium and you're manually verifying the formula still works. In Sourcetable, you upload your two legs and ask: "What's my net cost for the synthetic forward?"
The AI instantly returns $4.50 per share, recognizing that you're paying $32.50 for the call and collecting $28.00 for the put. No formulas. No cell references. No manual updates. Change the strike from $870 to $880 and the net cost recalculates automatically before you finish typing.
Automatic Breakeven and Payoff Modeling
Breakeven for a long synthetic forward is straightforward algebra: strike price plus net debit (or minus net credit if you collected premium). But when you're comparing six different strikes with different net costs, tracking breakevens manually becomes error-prone. Ask Sourcetable: "Show me breakevens for synthetic forwards at all available strikes."
It returns a sorted table: $850 strike → $853.80 breakeven, $870 strike → $874.50 breakeven, $890 strike → $891.20 breakeven. You immediately see which strike offers the most favorable entry point based on current stock price. Follow up with "Show payoff diagram for the $870 strike" and Sourcetable generates a publication-quality chart comparing your synthetic position against actually owning 100 shares—the lines overlap perfectly, proving synthetic replication.
Capital Efficiency Comparison
This is where synthetic forwards shine—and where Excel analysis falls apart. Capital requirements for stock ownership are simple: stock price times shares. But synthetic forward margin requirements depend on broker-specific formulas involving strike price, net debit, and regulatory requirements. The calculation typically looks like: 20% of strike value + net debit - out-of-the-money amount, but this varies.
In Sourcetable, ask: "Compare capital requirements for synthetic forward versus buying 200 shares." The AI calculates both scenarios. Buying 200 shares at $875 requires $175,000 in cash or $87,500 in margin (plus $1,750 interest over 90 days). The synthetic position requires $35,800 in margin (approximately $17,900 per contract based on 20% of $870 strike) plus your $900 net debit, totaling $36,700. That's 79% less capital for identical exposure—and the AI shows this comparison in a clean table without touching a formula.
Dividend and Interest Cost Analysis
Here's where Excel truly collapses. Stock owners receive dividends. Synthetic forward holders don't—dividends accrue to whoever holds the underlying shares, not option holders. But synthetic positions avoid margin interest costs. Which is better? It depends on dividend yield, interest rates, and time horizon.
Ask Sourcetable: "Factor in NVDA's $0.16 quarterly dividend and 8% margin interest—which is better over 90 days?" The AI calculates:
- Stock ownership: Collect $32 in dividends (200 shares × $0.16), pay $1,750 in margin interest. Net cost: $1,718.
- Synthetic forward: Miss $32 in dividends, avoid $1,750 in interest. Net savings: $1,718.
- Verdict: Synthetic forward is superior—you save $1,718 in net costs while deploying $50,800 less capital.
This kind of total return analysis would require building a separate calculator in Excel with inputs for dividend schedules, interest rates, and time-weighting. Sourcetable does it conversationally, adjusting assumptions in real-time as you refine your scenario.
Greek Exposure and Position Behavior
Understanding how your synthetic forward behaves before expiration requires analyzing Greeks. Synthetic forwards have unique Greek profiles: delta near +1.0 (perfect stock replication), gamma and vega near neutral (long call offsets short put), and theta near neutral (time decay from both sides cancels out).
Ask Sourcetable: "What's my delta?" It returns: +0.98 per contract—your position moves $0.98 for every $1 move in NVDA. Follow up with "Explain my theta exposure" and the AI calculates: -$0.12 per day. The long call loses $0.18 daily to time decay, the short put gains $0.06 daily, resulting in net theta of -$0.12. Your position bleeds $12 per day across 100 shares—minimal compared to the $4,375 swing from a $5 stock move (driven by delta).
This Greek aggregation would require referencing options pricing models or broker data, then manually netting values across both legs. Sourcetable does it instantly and explains the practical implications in plain language.
When Synthetic Forwards Beat Direct Stock Ownership
Synthetic forwards aren't always the optimal choice. Understanding when they provide genuine advantages—versus when they introduce unnecessary complexity—separates sophisticated traders from checkbox strategy users.
Best Use Cases for Synthetic Forwards
Capital-Constrained Traders: You have $50,000 available but want exposure to $200,000 worth of stock. Synthetic forwards let you control 4x the position size using margin efficiently. Just ensure you understand the leverage risk—losses scale with exposure.
Tax Loss Harvesting: You hold shares with unrealized losses and want to harvest the tax benefit without losing exposure. Sell the stock, realize the loss, immediately establish a synthetic forward. Wash sale rules don't apply the same way to options, giving you 30 days to maintain exposure while capturing the deduction.
Pattern Day Trader Restrictions: Accounts under $25,000 face day trading limits. A synthetic forward is technically one position (despite two legs), allowing you to establish and close bullish exposure without triggering PDT rules the same way stock trades do.
Pre-Earnings Positioning: You want overnight exposure to earnings but don't want to deploy full capital. A synthetic forward at a nearby strike gives you dollar-for-dollar participation for a fraction of the capital commitment.
Dividend Arbitrage Situations: In rare cases where implied volatility mispricing creates synthetic forwards with net credits (you get paid to establish the position), you're getting paid to hold bullish exposure. This happens when put premiums are temporarily inflated relative to call premiums.
When to Avoid Synthetic Forwards
High Dividend Stocks: If the stock pays a 4% annual dividend and you're holding for six months, you're giving up 2% in dividend income. Unless margin interest savings exceed dividend losses, direct ownership is superior.
Long-Term Buy-and-Hold: Synthetic forwards require rolling to new expirations as contracts approach expiry. Over multi-year horizons, the transaction costs and bid-ask spreads accumulate. Just buy the stock.
Illiquid Options: Wide bid-ask spreads destroy the capital efficiency advantage. If you're paying $0.50 extra entering and another $0.50 exiting due to poor liquidity, you've given up $100 per contract—potentially your entire net debit advantage.
Volatile Underlyings with Wide Spreads: High implied volatility inflates both call and put premiums. While the net debit might still be reasonable, assignment risk on the short put becomes meaningful. If the stock gaps down through your strike, you're assigned 100 shares per contract—suddenly you own the full position anyway.
Sourcetable helps you evaluate these trade-offs instantly. Ask: "Should I use a synthetic forward or buy NVDA stock given current dividend yield and interest rates?" The AI factors in all relevant costs and returns a recommendation based on your time horizon and capital constraints.
Multi-Strike Scenario Analysis: Finding the Optimal Entry
One underappreciated advantage of synthetic forwards is strike flexibility. Unlike buying stock at market price, you can establish synthetic positions at strikes above or below the current stock price, adjusting your breakeven and capital requirements based on your outlook.
With NVDA at $875, you might consider:
- $850 strike: In-the-money call, in-the-money put. Lower breakeven ($853.80), higher net debit ($3.80), lower margin requirement.
- $870 strike: At-the-money call and put. Moderate breakeven ($874.50), moderate net debit ($4.50), moderate margin.
- $890 strike: Out-of-the-money call, out-of-the-money put. Higher breakeven ($891.20), higher net debit ($1.20), higher margin requirement.
Which is optimal? It depends on your conviction level and capital availability. In Excel, comparing these scenarios requires duplicating your entire model three times and manually updating strikes. In Sourcetable, ask: "Compare synthetic forwards at $850, $870, and $890 strikes—show net debit, breakeven, margin requirement, and return on capital if NVDA hits $950."
The AI generates a comparison table instantly:
| Strike | Net Debit | Breakeven | Margin Req. | P&L at $950 | ROC |
|---|---|---|---|---|---|
| $850 | $3.80 | $853.80 | $17,380 | $9,620 | 55.4% |
| $870 | $4.50 | $874.50 | $17,850 | $7,550 | 42.3% |
| $890 | $1.20 | $891.20 | $17,920 | $5,880 | 32.8% |
Now you can make an informed decision. The $850 strike offers the highest return on capital if your bullish thesis plays out, but requires the stock to move less to reach breakeven. The $890 strike demands stronger conviction (stock must rally above $891 to profit) but has lower net debit. Sourcetable lets you explore these scenarios interactively—"What if NVDA only reaches $910?"—and updates the analysis in real-time.
Rolling Synthetic Forwards: Managing Positions Through Time
Synthetic forwards don't last forever. As expiration approaches, you face three choices: close the position (take profits or losses), accept assignment (short put turns into long stock), or roll to the next expiration. Rolling means closing your current synthetic forward and opening a new one at a later expiration date.
Let's say you established a synthetic forward at the $870 strike with 90 days to expiration for a $4.50 net debit. NVDA rallied to $920 over 60 days—you're sitting on a $50 unrealized gain per share (from your $874.50 breakeven to $920). But you have 30 days remaining and still believe in the bull thesis. Should you roll to the next expiration?
Ask Sourcetable: "Should I roll my $870 synthetic forward to next month?" The AI calculates:
- Cost to close current position: Buy back the $870 put for $1.20, sell the $870 call for $53.50. Net credit: $52.30 (you receive money closing the position).
- Cost to open new position at $920 strike: Buy the $920 call for $28.40, sell the $920 put for $26.10. Net debit: $2.30.
- Net roll cost: $52.30 credit received minus $2.30 debit paid = $50.00 net credit. You lock in your $50 gain and establish a new synthetic forward at $920.
The AI then explains: "Rolling locks in your $5,000 gain per contract and resets your position with 30 days of new time value. Your new breakeven is $922.30. This makes sense if you expect continued upside—otherwise, take the profit and deploy capital elsewhere."
This kind of roll analysis would take 20 minutes in Excel—pulling new option prices, calculating close costs, calculating open costs, comparing scenarios. Sourcetable does it conversationally in seconds and frames the decision clearly.
Portfolio-Level Synthetic Forward Management
Professional traders don't run one synthetic forward—they run five or ten simultaneously across different underlyings, strikes, and expirations. This creates a capital-efficient equity portfolio with defined margin requirements and continuous exposure. Managing this in Excel is chaos: ten separate spreadsheets, manual consolidation for portfolio Greeks, no way to track aggregate return on capital.
Sourcetable centralizes everything. Upload all positions and ask portfolio-level questions:
- "What's my total portfolio delta?" → +1,840 (equivalent to owning 1,840 shares across all positions).
- "Show total capital deployed versus equivalent stock purchase cost." → $127,400 in margin vs. $620,000 for stock—79.5% capital savings.
- "Which synthetic forwards are near breakeven?" → TSLA $245 strike is $2 from breakeven, AMZN $178 strike is $5 from breakeven.
- "What's my return on capital if all positions close at current prices?" → +18.6% across the portfolio.
This kind of aggregated analysis would require VBA macros, manual data pulls, and hours of spreadsheet engineering. In Sourcetable, it's a single question. The AI understands that when you ask about "total delta," you mean the sum across all synthetic forward positions, weighted by contracts and position direction.
Key Takeaways
The long synthetic forward replicates stock ownership dollar-for-dollar using options: buy a call and sell a put at the same strike and expiration. You gain full upside and downside exposure with 70-85% less capital than buying shares.
Traditional Excel analysis requires calculating net debit/credit, determining breakevens, modeling payoffs, comparing capital requirements, factoring dividends and interest costs, and tracking Greeks—a 45-minute process that breaks when premiums change.
Sourcetable turns synthetic forward analysis into natural language questions: "What's my net cost?" → $4.50. "Compare capital requirements to buying stock." → 79% less capital. "Should I roll to next month?" → Full roll cost analysis in seconds.
Synthetic forwards work best when you're capital-constrained, harvesting tax losses while maintaining exposure, avoiding pattern day trader restrictions, or positioning for short-term catalysts without deploying full capital.
Avoid synthetic forwards with high-dividend stocks over long time horizons, illiquid options with wide spreads, or true buy-and-hold strategies where rolling costs accumulate. Direct stock ownership is simpler and often cheaper long-term.
Professional traders run multiple synthetic forwards across different underlyings to create capital-efficient equity portfolios. Sourcetable aggregates portfolio-level Greeks, margin requirements, and return on capital instantly—analysis that would take hours in Excel.
Frequently Asked Questions
If your question is not covered here, you can contact our team.
Contact UsWhat is a long synthetic forward in options trading?
How do you calculate the breakeven for a synthetic forward?
What are the margin requirements for synthetic forwards?
Do synthetic forwards receive dividends?
When should you roll a synthetic forward to a new expiration?
What's the difference between synthetic forwards and buying stock?
How does Sourcetable help with this strategy analysis?
